There is no universal best treatment for sleep apnea. A useful plan starts by identifying the kind of breathing problem, then matches treatment to symptoms, sleep-study findings, health conditions, anatomy, preferences, and the response seen on follow-up.
Most of this guide compares adult treatment options. Children need a pediatric pathway because their causes, test interpretation, and treatment choices differ.
Start with obstructive versus central apnea
Obstructive sleep apnea (OSA) occurs when the upper airway narrows or closes despite continued effort to breathe. Central sleep apnea (CSA) occurs when breathing effort repeatedly decreases or stops. A person can also have both types, including central events that appear after treatment begins 12.
This distinction matters because a treatment that holds an obstructed airway open does not automatically correct unstable breathing control. The sleep study, medical history, medicines, heart and lung health, and treatment data help a clinician identify what is happening.
| Treatment path | Where it may fit | Important limit |
|---|---|---|
| CPAP or APAP | A first option for many adults with OSA | Requires fitting, education, troubleshooting, and review of use and efficacy data 1 |
| Custom oral appliance | Adult OSA when a person prefers it or cannot tolerate CPAP | Needs a qualified dentist, adjustment, dental follow-up, and a sleep test to confirm control 3 |
| Weight-management care | An additional treatment when excess weight is relevant to the person's OSA and health goals | Improvement varies, OSA can remain, and existing treatment should continue until reassessment 45 |
| Positional therapy | OSA shown on testing to be substantially worse on the back | CPAP lowers breathing events more on average, and studies have mostly been short 6 |
| Upper-airway or jaw surgery | Selected anatomy, PAP intolerance, or a need to make PAP easier to use | The procedure and expected benefit depend on the site of obstruction, and residual OSA is possible 7 |
| Hypoglossal nerve stimulation | Selected adults with OSA who meet device-specific criteria after PAP has failed or cannot be tolerated | Requires an implant, anatomical screening, activation, adjustment, and objective follow-up 85 |
| Cause-specific CSA treatment | Selected people with CSA due to heart failure, medicines or substances, high altitude, another condition, or no identified cause | Evidence is generally low or very low certainty, and the appropriate device or medicine depends on the cause 2 |
The table is a comparison, not a treatment ladder. Several options can be used together, and a reasonable alternative that a person can use consistently may work better in daily life than a theoretically stronger option they cannot use.
How clinicians choose an OSA treatment
An apnea-hypopnea index, or AHI, is only one part of the decision. Clinicians also consider:
- daytime sleepiness, impaired sleep-related quality of life, and driving or work risk
- oxygen changes, event duration, sleep stage, and whether events mainly occur on the back
- high blood pressure, heart or lung disease, neuromuscular disease, pregnancy, and other health conditions
- nasal, throat, tongue, jaw, and facial anatomy
- medicines or substances that may affect breathing
- previous treatment response, side effects, practical access, and personal priorities
Treatment should be based on an established diagnosis, not snoring, a wearable score, or an overnight oxygen reading alone. PAP guidelines specifically call for objective diagnosis plus ongoing monitoring of effectiveness and use 1.
PAP is the most established OSA option
Positive airway pressure, or PAP, sends pressurized air through a mask to keep the airway open. CPAP provides a fixed pressure, while APAP adjusts within a prescribed range. For routine adult OSA, the American Academy of Sleep Medicine supports either CPAP or APAP and generally favors them over starting bilevel PAP. Bilevel devices have separate uses when higher pressures or another breathing disorder requires them, but they are not automatically more comfortable or more effective for ordinary OSA 1.
PAP has its clearest evidence for adults with excessive sleepiness. It can also improve sleep-related quality of life and produce a modest average blood-pressure benefit in people who have hypertension. Evidence has not established that prescribing PAP to every adult without sleepiness prevents heart attacks, strokes, or death, so those outcomes should not be promised 1.
A difficult first week does not prove PAP has failed. Useful troubleshooting includes checking mask size and style, leak, dry mouth, nasal symptoms, humidification, pressure discomfort, claustrophobia, insomnia, and the device download. Education and early troubleshooting improve PAP use on average 1. Ask the treating team to review the problem rather than changing pressure ranges or abandoning treatment on your own.
An oral appliance is a prescription treatment, not a store-bought mouth guard
A sleep-apnea oral appliance usually moves the lower jaw forward to create more room behind the tongue. The guideline-supported version is custom-made and adjustable, prescribed through a sleep clinician and managed by a qualified dentist. It is a reasonable option for an adult who cannot tolerate CPAP or prefers an alternative 3.
CPAP generally reduces AHI, arousals, and oxygen disturbance more than oral appliances, although an oral appliance can improve sleepiness and quality of life in selected people. Comfort does not confirm that it is controlling apnea. Dental or bite changes also need monitoring, and a follow-up sleep study should verify effectiveness after the appliance has been adjusted 3.
Weight care can help without being a universal prerequisite
For adults with OSA who have overweight or obesity, an American Thoracic Society guideline recommends a comprehensive program that combines nutrition, physical activity, and behavioral support. Medicines or bariatric surgery may also be considered for selected people as part of broader obesity care 4.
Weight change can reduce OSA severity, but the response is not identical for everyone and apnea may persist after substantial loss. Airway anatomy and other contributors still matter. Continue the current OSA treatment unless the treating clinician confirms that it can be changed, and consider repeat testing after a clinically significant weight change 5.
Tirzepatide is not a general sleep-apnea drug. In the United States, the FDA approved it for moderate-to-severe OSA in adults with obesity, together with a reduced-calorie diet and increased physical activity. The supporting trials included adults using PAP and adults unable or unwilling to use PAP, and the AHI improvement appeared to be related largely to weight reduction 9. Eligibility, side effects, contraindications, cost, and how it fits with existing treatment require a prescribing clinician.
Positional therapy only fits position-dependent OSA
Positional therapy aims to reduce time sleeping on the back. It makes sense when the diagnostic study shows substantially fewer events in another position, not simply because side sleeping feels easier. A Cochrane review found that CPAP reduced AHI more than positional therapy, while positional therapy appeared easier to use in the short studies available. Long-term effectiveness and effects on quality of life remain less certain 6.
A pillow or an instruction to sleep on your side does not prove apnea is controlled. If positional therapy is chosen, use the sleep-study pattern to guide the choice and confirm that the plan controls symptoms and breathing.
Surgery is anatomy-specific
“Sleep apnea surgery” includes procedures with very different targets, such as the nose, tonsils, palate, tongue base, or upper and lower jaws. Surgery may be discussed when PAP is unacceptable or poorly tolerated, when a correctable anatomical problem is present, or when a procedure may reduce pressure-related PAP difficulty. The AASM referral guideline emphasizes a patient-specific consultation rather than naming one operation as best 7.
A sleep surgeon should explain the target, likely benefit, recovery, complications, and chance of residual OSA. Nasal surgery, for example, may improve airflow or make PAP easier to use without curing collapse elsewhere in the airway. Symptom improvement after any operation is not enough to assume that OSA has resolved.
Hypoglossal nerve stimulation is one surgical option, not a general replacement for CPAP. A US-approved system is intended for a selected subset of people with moderate-to-severe OSA who cannot use PAP successfully and who meet anatomical and other device-specific criteria 8. Candidacy rules and insurance policies can differ. After implantation, the system must be activated and adjusted, and sleep testing is used to optimize and verify treatment 5.
Central sleep apnea follows a different treatment path
CSA is not one disease with one preferred machine. It can be associated with heart failure, opioid or other substance exposure, high altitude, another medical or neurological condition, or no identified cause. Treatment first addresses the underlying condition and the outcomes that matter to the person, not just removal of every central event 2.
The 2025 AASM guideline gives only conditional recommendations, based on low or very low certainty evidence, for options that may include CPAP, bilevel PAP with a backup rate, adaptive servo-ventilation (ASV), low-flow oxygen, acetazolamide, or transvenous phrenic nerve stimulation. The appropriate option depends on the CSA subtype. The same guideline suggests against bilevel PAP without a backup rate for CSA because it can worsen central events 2.
Heart failure requires particular care. In the SERVE-HF trial, one ASV approach increased all-cause and cardiovascular mortality in people with symptomatic heart failure, a left-ventricular ejection fraction of 45% or less, and predominantly central apnea 10. Newer evidence has complicated the question of whether that risk applies to every ASV device. Current AASM guidance says ASV for heart failure with reduced ejection fraction should be limited to experienced centers with close monitoring and shared decision-making 2.
Oxygen and acetazolamide are also prescriptions, not home experiments. Do not borrow oxygen, change its flow, start a diuretic-like medicine, stop an opioid abruptly, or select a ventilatory mode without the clinicians managing the relevant condition.
What is not a substitute for verified treatment
Mouth taping is not an established OSA treatment. A 2025 systematic review found that the small and varied studies did not provide strong support for using mouth tape or another device that closes the mouth to improve OSA 11. Do not use it in place of PAP, a fitted oral appliance, or another prescribed treatment.
Nasal strips, ordinary pillows, and herbal sleep aids may change comfort or a symptom without controlling the underlying breathing disorder. Treating nasal congestion or dry mouth may make PAP easier to use, but it is troubleshooting, not proof that apnea itself has been treated.
Myofunctional exercises are sometimes offered as an adjunct for OSA. Evidence is limited, and the European Respiratory Society guideline recommends against choosing them instead of CPAP 12. If an adjunct seems helpful, keep the established treatment in place until objective reassessment shows that a change is safe.
Follow-up is part of treatment
A treatment plan should answer three separate questions:
- Are you using it? PAP downloads, appliance wear, positional-device data, and practical barriers provide different kinds of information.
- Is it controlling the breathing problem? Device estimates can help but do not replace clinician interpretation or a sleep study when objective reassessment is indicated.
- Are the outcomes that matter improving? Review sleepiness, alertness, sleep quality, blood pressure when relevant, side effects, and daily function.
Adults doing well on PAP do not need routine repeat sleep studies solely because time has passed. Repeat testing is appropriate when symptoms persist or return, device data are unexplained, weight changes substantially, relevant cardiovascular disease changes, or a non-PAP treatment needs verification 5.
Do not stop PAP because snoring improved, a wearable looks better, or weight changed. Do not change pressure, oxygen, a prescription medicine, or an implanted-device setting outside the limits and plan provided by the treating team.
Treatment is different for children
In uncomplicated childhood OSA with enlarged tonsils and adenoids, adenotonsillectomy is often the first treatment considered. CPAP and other options may be used when surgery is not appropriate or OSA persists, and children need reassessment because surgery does not always remove every obstruction 13. Infants, medically complex children, and children with central apnea need specialist evaluation rather than an adult treatment algorithm.
The bottom line
The right sleep apnea treatment is the one that matches the type and cause of the breathing disorder, is practical enough to use, and is shown to work. PAP is the most established option for many adults with OSA, but it is not the only legitimate choice. Oral appliances, weight care, positional therapy, surgery, medication, and implanted stimulation each have a defined place and meaningful limits. CSA needs a separate, cause-specific plan.
If treatment is uncomfortable or appears ineffective, ask for troubleshooting and objective review before giving up. A change in symptoms is useful information, but follow-up data are what show whether breathing during sleep is adequately controlled.
